Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Editas Medicine Inc shares valued at $1,752 were sold by Parison Amy on Aug 07 ’25. At $2.58 per share, Parison Amy sold 679 shares. The insider’s holdings dropped to 16,827 shares worth approximately $49807.92 following the completion of this transaction.
Also, Burkly Linda sold 5,121 shares, netting a total of over 12,757 in proceeds. Following the sale of shares at $2.49 each, the insider now holds 64,398 shares.
Before that, Burkly Linda had added 7,500 shares to its account. In a trade valued at $25,950, the Officer bought Editas Medicine Inc shares for $3.46 each.
As published in their initiating research note from H.C. Wainwright on April 28, 2025, Editas Medicine Inc [EDIT] has been a Buy and the price target has been revised to $3. Analysts at JP Morgan downgraded the stock from ‘”a Neutral”‘ to ‘”an Underweight”‘ outlook in a report released in mid December. As of December 13, 2024, Truist has decreased its “Buy” rating to a “Hold” for EDIT. Earlier on December 13, 2024, Stifel downgraded its rating. Their new recommendation was “a Hold” for EDIT stock which previously was a “a Buy”.
Analyzing EDIT Stock Performance
On last trading session, Editas Medicine Inc [NASDAQ: EDIT] plunged -3.90% to $2.96. The stock’s lowest price that day was $2.9, but it reached a high of $3.105 in the same session. During the last five days, there has been a surge of approximately 18.88%. Over the course of the year, Editas Medicine Inc shares have dropped approximately -24.49%. Shares of the company reached a 52-week high of $3.58 on 07/24/25 and a 52-week low of $0.91 on 04/07/25.
Support And Resistance Levels for Editas Medicine Inc (EDIT)
According to the 24-hour chart, there is a support level at 2.87, which, if violated, would cause prices to drop to 2.77. In the upper region, resistance lies at 3.08. The next price resistance is at 3.20. RSI (Relative Strength Index) is 57.92 on the 14-day chart, showing neutral technical sentiment.
Is Editas Medicine Inc subject to short interest?
Stocks of Editas Medicine Inc saw a sharp steep in short interest on 2025-07-31 dropping by -0.88 million shares to 7.85 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 8.73 million shares. A decline of -11.18% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.64 of the overall float, the days-to-cover ratio (short ratio) decline to 2.64.
Which companies own the most shares of Editas Medicine Inc (EDIT)?
In terms of Editas Medicine Inc share price expectations, FactSet research, analysts set an average price target of 12 in the next 12 months, up nearly 289.61% from the previous closing price of $3.08. Analysts anticipate Editas Medicine Inc stock to reach 35 by 2025, with the lowest price target being 5. In spite of this, 9 analysts ranked Editas Medicine Inc stock as Buy at the end of 2025.
